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ABSTRACT 
 
Background 
South Africa is grappling with a quadruple burden of disease, and cardiovascular 
diseases with other non-communicable diseases are on the increase. 
Echocardiography is an expensive but vital basic screening and diagnostic tool 
for cardiac patients. Appropriate use criteria (AUC) have been developed for 
echocardiography to assist with avoiding unnecessary echocardiograms.  
 
Aim and Objectives of the study 
The aim of the study was to determine the clinical appropriateness of referrals to 
the echocardiography clinic at Chris Hani Baragwanath Academic Hospital using 
AUC. The specific objectives were: 
1. Describe the socio-demographic profile of patients referred for 
echocardiography 
2. Determine the clinical appropriateness of echocardiography referrals 
3. Describe the clinical profile of patients referred for echocardiography 
4. Determine whether socio-demographic and clinical profile influence the 
appropriateness of echocardiography referral 
 
Methods 
During July 2015, a cross-sectional study was conducted among all new patients 
referred to the echocardiography clinic at the Chris Hani Baragwanath Academic 
Hospital (CHBAH). Following informed consent, patient demographic information 
was collected. Clinical and echocardiography reports were obtained for all new 
patients and analyzed, using the 2011 AUC criteria for echocardiography. 
The data were analysed using Minitab version 16.  
 
Results 
The majority of the study participants (n=270) were black African (88.3%); they 
had a mean age of 53 years (SD ±16.6) and 63.1% were female. The study 
found that 93.3% of new patients were appropriately referred, 3.7% (n=10) were 
inappropriately referred and 3.0% (n=8) had uncertain indications for 
echocardiography. Hypertension 45.5% (n=123/270) was the most common 
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clinical diagnosis on echocardiogram request, with the post-echocardiogram 
evaluation confirming that 41.6% (111/267) of all the patients had hypertensive 
heart disease. An HIV positive status was documented in only 10.6% (n=29) of 
the patients.  
 
Conclusion 
The AUC is a useful tool and yielded similar results at the CHBAH. There is a 
high burden of hypertensive heart disease in this population, which requires 
specific prevention strategies.  
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CHAPTER 1: INTRODUCTION AND LITERATURE REVIEW 
 
1. Background 
Non-communicable diseases (NCDs) constitute a major and growing public 
health problem (Murray and Lopez, 2013). NCDs are diseases or conditions that 
affect individuals over an extended period of time, and for which there are no 
known causative agents that are transmitted from one individual to another 
(Murray and Lopez, 2013). The 2010 global burden of disease study found that 
NCDs such as ischemic heart disease and stroke, were among the top ten 
causes of disability adjusted life years (DALYs) lost (Murray and Lopez, 2013). In 
2015, the World Health Organization (WHO) estimated around 38 million NCD 
deaths each year, the majority (28 million) occurring in low- and middle-income 
countries (LMICs) (WHO, 2015). According to WHO projections, the total number 
of deaths from NCDs will increase to 55 million by 2030 if no decisive action is 
taken to prevent such deaths (WHO, 2013).  
 
South Africa is grappling with a heavy, quadruple burden of disease, namely 
maternal and child illnesses; infectious diseases such as Human 
Immunodeficiency Virus (HIV) and tuberculosis (TB); NCDs such as 
cardiovascular diseases and diabetes; and violence and injuries (Coovadia et al., 
2009). NCDs are on the increase due to a combination of demographic, 
epidemiological, environmental and dietary factors (Spires et al., 2016). 
Furthermore, the success of the country’s HIV treatment program means that 
people living with HIV (PLHIV) are surviving longer. Cardiovascular disease 
alone or as a consequence of HIV illness and its treatment as well as other 
lifestyle diseases are on the rise (including hypertension, diabetes, cancers and 
chronic respiratory diseases) (Becker et al., 2010). More and more Africans are 
presenting for care for acute coronary syndromes (ACS) at younger ages 
(Becker et al., 2010). At the same time, the health care system is not well 
equipped to deal with the demands of chronic disease care and treatment 
(Hofman, 2014). This is exacerbated by the high burden of valvular heart disease 
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due to rheumatic heart disease (RHD), especially in rural and poor urban 
communities.  
 
Globally rheumatic fever and rheumatic heart disease (RF/RHD) is the most 
common cardiovascular disease in children and young adults affecting about 
15.6 million people worldwide with 282 000 new cases and 233 000 deaths each 
year (Robertson et al., 2006). The widespread use of penicillin for the treatment 
of streptococcal pharyngitis and improvement in living conditions, has led to a 
dramatic decline in incidence and prevalence of RF/RHD in high-income 
countries.  
 
There is a dearth of information on RF/RHD in LMICs (Carapetis et al., 2005). 
The 2012 echocardiographic screening program in school-aged children found a 
prevalence of 4.9 per 1000 in Uganda, 2.3 per 1000 in Mozambique and 0.9 per 
1000 in India (Roberts et al., 2013). In South Africa, national prevalence data on 
RF/RHD is not available. A 1972 clinical study in Soweto, Johannesburg found a 
prevalence of 7.1 per 1000 schoolchildren, while a 1984 study in Inanda, Durban 
found a prevalence of 1.0 per 1000 schoolchildren (Robertson et al., 2006). A 
study undertaken in 2006 and 2007 by the adult Division of Cardiology at Chris 
Hani Baragwanath Academic Hospital (CHBAH) found a high incidence of new 
patients (23.5 per 100 000) presenting with RHD for the first time (Sliwa et al., 
2010).  The median age of diagnosis of RHD was 41 (interquartile range of 30-
55) in males and 42 (interquartile range 31-55) in females (Sliwa et al., 2010). In 
contrast there has been a noticeable decline in the pediatric population of acute 
rheumatic fever (ARF) at the same hospital over the past two decades (Cilliers, 
2014). 
 
At a population level, the screening for RHD has been enhanced by the evolution 
of echocardiography with its greatly improved sensitivity (Roberts et al., 2013). 
This has led to widespread request for the use of echocardiography to screen 
school going children for RHD during the period from 2007 to 2012. However, 
concerns have been raised about the specificity of echocardiography since the 
interpretation of minor abnormalities is posing new challenges (Roberts et al., 
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2013). These include mild mitral regurgitation which may be normal in young 
children.  
 
Although prevention remains the cornerstone of public health measures to 
reduce the disease burden of ARF and RHD (Robertson et al., 2006), secondary 
antibiotic prophylaxis aims at preventing recurrent attacks of ARF, which is a 
major risk factor of RHD. However, despite the existence of Department of 
Health secondary prophylaxis guidelines (Republic of South Africa), adherence to 
these guidelines has been suboptimal (Robertson et al., 2005). In light of the 
declining incidence of ARF in South Africa, echocardiographic screening has 
been suggested for the diagnosis of RHD (Cilliers, 2014), because 
echocardiography would diagnose asymptomatic or sub-clinical RHD in patients 
who could be targeted for secondary antibiotic prophylaxis.  
 
If the above interventions do not yield the desired results during childhood and 
early adulthood these patients present in late adulthood with established 
rheumatic valvular heart disease, with the majority of them requiring expensive, 
high risk cardiothoracic surgical intervention. Furthermore, some referred 
patients present too late to hospital when very little can be done from a clinical 
perspective to assist them. 
 
This situation is exacerbated by the large number of patients awaiting surgical 
intervention at the cardiothoracic surgery department at the Charlotte Maxeke 
Johannesburg Academic Hospital (CMJAH) in Gauteng Province (Papo, 2013). 
In 2015, almost half of these patients awaiting surgery were referred by the 
Division of Cardiology at the CHBAH. Many of these patients awaiting surgery 
will not have their operations timeously with devastating consequences, which 
include recurrent hospital admissions, complications and death. The situation is 
further complicated by complaints from cardiologists in the Division of Cardiology 
at CHBAH of unnecessary, inappropriate and excessive referrals to the 
echocardiography clinic, which put medical and nursing staff under undue 
pressure. This is because the echocardiography clinic does the initial 
assessment of the majority of patients who need cardiology services, prior to 
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their referral to other specialist clinics within the CHBAH, or back to their 
respective hospitals and primary health care (PHC) clinics.  
 
In light of the challenges highlighted above, the aim of this study was to examine 
the clinical appropriateness of referrals to the echocardiography clinic at the 
CHBAH, in order to make recommendations on: 
 The possible development or revision of referral criteria to the Echo clinic to 
ensure that the diagnostic tool of echocardiography is used appropriately and 
cost-effectively; 
 Possible strategies to reduce missed opportunities for secondary prevention 
of cardiac complications due to RF/RH. 
 
The remainder of this chapter sets the scene for the study that was conducted by 
describing the study setting, outlining the problem statement, presenting a review 
of existing literature, and summarizing the rationale for the study. The chapter 
concludes with the study aim and objectives. 
 
1.2  Study Setting 
The setting for the study was the echocardiography clinic in the Division of 
Cardiology at the CHBAH.  
CHBAH is one of South Africa’s ten central hospitals, and one of the four central 
hospitals in Gauteng Province (Don-Wauchope et al., 2010). It is one of South 
Africa’s busiest central hospitals, the world’s third largest hospital, and one of the 
teaching hospitals of the University of the Witwatersrand, Johannesburg. The 
hospital occupies 173 acres of land, and has 3 200 beds and about 6 760 staff 
members. Every year about 150 000 inpatient and 500 000 outpatient cases are 
recorded.  
The Department of Medicine admits around 120 patients per day and is one of 
the busiest in the country. Within the Department of Medicine, the Division of 
Cardiology of the CHBAH is a referral center for the estimated Soweto population 
of 1.2 million, Southern Gauteng, Heidelberg and parts of the North West 
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Province. The division is also a referral center for other sub-Saharan African 
countries, notably Swaziland, Lesotho, Zimbabwe and Botswana. The majority of 
patients who need cardiology services are referred to the echocardiography clinic 
for initial assessment, and then referred to other specialist clinics within the 
Division of Cardiology or back to their respective hospitals and PHC clinics for 
follow up. Echocardiography clinic referral criteria are communicated to referring 
clinicians periodically and on a per need basis because junior medical staff i.e. 
registrars, medical officers and interns rotate within different divisions at least 
every four months.   
The red star on the map in Figure1.2 below shows the approximate location of 
the CHBAH in Soweto, Gauteng Province.  
 
Figure 1.2: Map of Gauteng (2016)  
(Source: www.places.co.za)  
 
At the time of the study, the researcher was a cardiology fellow in the Division of 
Cardiology at CHBAH, providing clinical care in both the medical wards, and 
consulting patients in the echocardiography clinic. 
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1.3 Problem statement 
The study was premised on the following: 
1. There is a dearth of information on the socio-demographic and/or clinical 
 profile of patients referred to the echocardiography clinic. 
2. There is a lack of information on the clinical appropriateness of referrals to 
the echocardiography clinic at the CHBAH.  
3. As the CHBAH is a tertiary referral center, there are a lot of patient referrals 
to the echocardiography clinic, resulting in long patient waiting times and 
heavy staff load, at times frustration as well as conflict among the referring 
clinicians on the one hand, and staff at the echocardiography clinic on the 
other hand. This is exacerbated by the perceptions among 
echocardiography clinic staff that there are a lot of inappropriate referrals to 
the clinic. 
 
1.4  Literature Review 
1.4.1 Definition of terms 
Echocardiogram 
An echocardiogram is the use of ultrasound to study the structure and function of 
the heart and the blood vessels (Armstrong, 2010). It is routinely used in the 
diagnosis, management and follow-up of patients with suspected or known 
cardiac disease (Armstrong, 2010). Types of tests that are performed typically 
include trans-thoracic echocardiography (TTE), trans-esophageal 
echocardiography (TEE) and three-dimensional echocardiography (3D E). 
 
Appropriate use criteria for echocardiography  
Appropriate use criteria (AUC) are a set of criteria developed by the American 
College of Cardiology Foundation in response to the dramatic growth rate of 
cardiac imaging and concerns about excessive utilization (Douglas et al., 2007). 
They are meant to eliminate unnecessary testing and promote optimal patient 
care (Douglas et al., 2007). They were initially developed in 2007 and then 
revised in 2011 (Douglas et al., 2007). Prior to 2007 there was no validated tool 
to guide echocardiography requests and use. Echocardiography is a high cost 
7 
diagnostic imaging modality and the appropriateness of its use improves the 
overall quality of service rendered to the patient. 
 
AUC of echocardiography are scored on a scale of 1 to 9, with 7 to 9 deemed 
appropriate use, 4 to 6 uncertain use and 1 to 3 inappropriate use (Douglas et 
al., 2007). These criteria are meant to guide the rationale use of 
echocardiography. The table below shows the various categories of 
echocardiography use and Appendix 7 is a full list of the criteria and their scoring. 
 
Table 1.4.1: Appropriate Use criteria categories 
 
 Appropriate Use Criteria Categories 
1 TTE for general evaluation of cardiac structure and function 
 Suspected Cardiac Etiology-General with TTE 
 Arrhythmias with TTE  
 Light-headedness/Pre-syncope/Syncope with TTE 
 Evaluation of Ventricular Function with TTE 
 Perioperative Evaluation with TTE 
 Pulmonary Hypertension with TTE 
2 TTE for Cardiovascular evaluation in an Acute setting   
 Hypotension or Hemodynamic Instability with TTE 
 Myocardial Ischemia/Infarction with TTE 
 Evaluation of Ventricular Function after ACS with TTE 
 Respiratory Failure with TTE 
 Pulmonary Embolism with TTE 
 Cardiac Trauma with TTE 
3 TTE for evaluation of valvular function 
 Murmur or Click with TTE 
 Native Valvular Stenosis with TTE 
 Native Valvular Regurgitation with TTE  
 Prosthetic Valves With TTE 
 Infective Endocarditis (Native or Prosthetic Valves) With TTE 
 TTE for evaluation of intra-cardiac and extra-cardiac structures 
and chambers 
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 Appropriate Use Criteria Categories 
 TTE for evaluation of aortic disease 
4 TTE for evaluation of hypertension, HF, or cardiomyopathy 
 Hypertension With TTE 
 HF With TTE 
 Device Evaluation (Including Pacemaker, ICD, or CRT) with TTE 
 Ventricular Assist Devices and Cardiac Transplantation With TTE 
 Cardiomyopathies With TTE 
 TTE for adult congenital heart disease 
5 TEE 
 TEE as Initial or Supplemental Test—General Uses 
 TEE as Initial or Supplemental Test—Valvular Disease 
 TEE as Initial or Supplemental Test—Embolic Event    
 TEE as Initial Test—Atrial Fibrillation/Flutter 
 
1.4.2 Studies on clinical appropriateness of echocardiography referrals 
In the United States of America (USA), AUC have been evaluated at academic 
medical centers and community settings and several common themes emerged 
(Douglas et al., 2007). The majority of clinical scenarios for which TTEs were 
ordered, were captured by AUC indications (11% to 16% of TTEs were 
unclassified) (Ward et al., 2008; Willens et al., 2009). Across the implementation 
studies there are remarkably similar rates of appropriate and inappropriate use of 
TTE. Among those with an AUC indication the majority were rated as appropriate 
(87% to 91%) and the rate of inappropriate TTEs was consistently low (9% to 
13%).  
 
Ballo et al in their 2011 study on AUC criteria in hospitalized patients found that 
the large majority of echocardiography indications (98.8%) were classifiable 
according to the AUC with good inter-observer reproducibility (Ballo et al., 2012). 
In their study, those cases with inappropriate indications were younger and 
patients were more often referred by non-cardiologists (Ballo et al., 2012). Most 
causes of inappropriate indications were related to the lack of change in clinical 
status or the absence of cardiovascular symptoms and signs (Ballo et al., 2012). 
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Examinations with appropriate or uncertain indications had an impact on clinical 
decision making more often than those with inappropriate indications (86.7% vs. 
14.1%, P<.001) (Ballo et al., 2012).  
 
The study also analyzed a group of discharged patients that were not referred for 
TTE and found out that TTE might have been appropriate in 16.2% of cases 
(Ballo et al., 2012). The authors concluded that the application of the AUC criteria 
were highly feasible in a community setting and recommended strategies to 
implement the AUC in clinical practice (Ballo et al., 2012).  
 
Ward et al (2009) compared the application of AUC for outpatient TTE in 
academic and community practice in the USA and found the criteria to be 
feasible (Ward et al., 2009). The study also found that the frequency of 
appropriate and inappropriate outpatient TTEs to be similar in academic and 
community practice settings (Ward et al., 2009). There were limitations of using 
the AUC, suggesting revisions were required to encompass the broad clinical 
practice of echocardiography in hospital and outpatient settings (Ward et al., 
2009). Some of these limitations were addressed in the revised AUC in 2011. 
Patil et al (2012) reported that TTE was appropriate in 82%, inappropriate in 
12.3%, uncertain in 5.3%, and non-fitting in 0.4% of the cases studied (Patil et 
al., 2012). 
 
A study to determine the applicability, limitations and downstream impact of 
echocardiography utilization based on AUC for trans-thoracic and trans-
esophageal echocardiography revealed that implementing AUC had a direct 
impact, as appropriate studies were significantly more likely to reveal new and 
major findings, and more likely to result in a patient care intervention based on 
echocardiography findings (Alqarqaz et al., 2012).  
 
Since the development of AUC published in 2007, the first study done outside the 
USA was a 2014 study in the United Kingdom (UK). In this UK study, the most 
common appropriate outpatient indication for echocardiography was “symptoms 
or condition potentially related to suspected cardiac etiology” (indication 1 in the 
AUC document), and this constituted 142 studies or 19.8% of all outpatient 
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studies (Gurzun and Ionescu, 2014). The proportion of appropriate cases was 
higher among inpatients compared with outpatients (94.4 vs. 83.5%, P <0.005) 
(Gurzun and Ionescu, 2014).  
 
There is a dearth of studies that have used AUC to examine appropriateness of 
echocardiography referrals in LMICs or outside the USA or UK (Gurzun and 
Ionescu, 2014) until 2014.  
 
1.4.3 Studies outside the UK and USA 
AI-Kaisey et al conducted a study in an Australian regional center and reported 
77% appropriate, 20.3% inappropriate, and 2.7 % uncertain TTE indications (AI-
Kaisey A, 2015). A 2016 study in Lebanon among 501 eligible patients found that 
374 patients (74.66%) were in the appropriate group, 85 patients (16.96%) in the 
inappropriate group, 20 patients (3.99%) in the uncertain group and 22 patients 
(4.39%) in the non-fitting category (Rameh and Kossaify, 2016). 
  
The researcher could not find any published studies that have examined the 
appropriateness of referrals to echocardiography clinics in South Africa. 
Furthermore, at the CHBAH, the majority of inpatient referrals for TTE are done 
by non-cardiologists, and there is little information available on the 
appropriateness of these referrals.  
 
In summary, the literature review found that there is a dearth of the studies on 
the clinical appropriateness of echocardiography referrals, using the AUC, 
especially in LMICs. The studies that have used the AUC are shown in 
Table1.4.3. 
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Table 1.4.3: Summary of studies that have assessed the clinical application of AUC in echocardiography 
 
 
Author and 
year of 
publication 
No. of 
Patients 
Setting AUC 
versio
n 
Appropriateness of 
requests for 
Echocardiography (%) 
Comments 
NC A U I 
1. Mansour et 
al.,  
2247 
(1553 
TTE) 
USA 
Academic 
2011 2 82 7 11 Abnormal findings more common in A than 
in I studies 
2. Bhatia et al., 
2012 
450 
USA 
Academic 
Community  
2007 11 89 0 11 I:30% in academic OPD, 21% in 
Community OPD, 14% in academic in-
patient setting 2011 2 71 7 22 
3 Bailey et al., 
2012 
1179 USA Regional 
Hospital  
2007 23 83 0 17 93% of undefined studies (2007) could be 
classified using 2011 AUC 
2011 
 
96.5 0.4 2.4 
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Author and 
year of 
publication 
No. of 
Patients 
Setting AUC 
versio
n 
Appropriateness of 
requests for 
Echocardiography (%) 
Comments 
NC A U I 
4 Alqarqaz et 
al., 2012 
170 USA 
Academic 
2007 13 86 0 1 A studies more likely to show new/major 
findings resulting in patient care or 
intervention 2011 
 
77 14 9 
5 Parikh et al., 
2012 
384 USA 
Academic 
2007 14 77 0 9 Revised criteria successful in addressing 
increased number of clinical conditions 
2011 5.5 92.2 0.5 1.8 
6 Ballo et al., 
2012 
931 USA 
Community 
Hospital, in-
patient 
2007 12.5 86.7 0 0.8 A and U indications impacted clinical care 
more often than I ones 
2011 1.2 80.3 5 14.7 
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Author and 
year of 
publication 
No. of 
Patients 
Setting AUC 
versio
n 
Appropriateness of 
requests for 
Echocardiography (%) 
Comments 
NC A U I 
7 Patil et al., 
2012 
1820 USA 
Academic 
2011 0.4 82 5.3 12.3 
 
8 Gurzun M.M 
and Inonescu 
A., 2014 
1070 
UK 
Academic in-
patient, 
Regional 
Hospital  
2011 
 
86 3 11 AUC yields similar results to USA 
9 AI-Kaisey et 
al., 
 
Australia 
Regional 
Centre 
2011 
 
77 2.7 20.3 
 
14 
 
Author and 
year of 
publication 
No. of 
Patients 
Setting AUC 
versio
n 
Appropriateness of 
requests for 
Echocardiography (%) 
Comments 
NC A U I 
10 Rameh et al., 
2016 
501 Lebanon 
Academic 
Hospital 
2011 4.39 74.6 3.99 16.9 
 
 
Table 1.4.3: Abbreviation references  
A:     Appropriate; 
NC:  Not Classifiable;  
U:    Uncertain 
I:     Inappropriate 
Acad:       Academic hospital;  
Regional: Regional hospital 
Comm:    Community hospital; 
in-pts:      In-patients 
OPD:       Outpatients department. 
 
(Mansour et al., 2012, Bhatia et al., 2012, Bailey et al., 2012, Alqarqaz et al., 2012, Parikh et al., 2012, Ballo et al., 2012, 
Patil et al., 2012, Gurzun and Ionescu, 2014, AI-Kaisey A, 2015, Rameh and Kossaify, 2016) 
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1.5  Justification for this study 
There were several reasons for conducting a study on the appropriateness of 
echocardiographic referrals to the Division of Cardiology at CHBAH. Firstly, this is 
a resource-limited environment where the utilization of resources has to be 
optimized, to prioritise only those who will derive the most benefit to access 
echocardiography. Secondly the study findings will provide a baseline for service 
monitoring for the team working in the echocardiography clinic at CHBAH, to 
assist them in their future training and guideline development initiatives. 
 
Since the development of the AUC criteria, their appropriateness and validity in a 
resource-limited setting outside the USA, UK, Australia and Lebanon have not 
been tested. This study will begin to address the knowledge gap, with useful 
insights for similar study settings, both in South Africa, and other LMIC settings. 
 
1.6  Aim and Objectives  
The aim of the study was to determine the clinical appropriateness of referrals to 
the echocardiography clinic at the CHBAH. The specific objectives of the study 
were to: 
1. Describe the socio-demographic profile of patients referred for 
echocardiography to the CHBAH; 
2. Describe the clinical profile of patients referred for echocardiography; 
3. Determine the clinical appropriateness of echocardiography referrals; and 
4. Determine whether socio-demographic and clinical profile influence the 
appropriateness of referral. 
 
The next chapter describes the study methodology.   
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CHAPTER 2: METHODOLOGY 
 
2.1 Introduction 
This chapter describes the overall study approach and methodology used to 
answer the questions posed in this study.  
 
2.2 Study Setting 
The study setting was the echocardiography clinic in the Division of Cardiology at 
the CHBAH, described in Chapter 1.  
 
2.3 Study Design 
This was a cross-sectional, study, conducted at a point in time (July 2015) at the 
CHBAH. 
 
2.4 Study Population 
The study population consisted of all the patients referred to the 
echocardiography clinic at the CHBAH. 
 
2.5 Study Period 
The study period was from 1 July 2015 to 31 July 2015. 
 
2.6 Ethical considerations 
Ethical approval was obtained from the Human Research Ethics Committee 
(Medical) of the University of the Witwatersrand, Johannesburg (Clearance 
number M150529 shown in Appendix 1a). The Gauteng Department of Health 
and the Chief Executive Officer of the CHBAH also approved the study 
(Appendix 1b). 
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All standard ethical procedures were adhered to. The researcher explained the 
research process to the support staff working in the echocardiography clinic, 
especially the importance of the providing information to all patients and 
obtaining consent for participation in the study. During July 2015, all new patients 
were informed about the research project and were given a detailed patient 
information sheet (Appendix 2) upon registration with the echocardiography clinic 
clerk. For those patients that could not understand the contents of the information 
sheet, the assistance of a translator was obtained to explain the study. Informed 
consent was obtained from every patient who participated in the study (Appendix 
3).  
 
Participation in the study was voluntary with no direct benefits or penalties for 
non-participation. After signing consent, participants were given their signed 
consent forms and advised to give these forms to their attending doctor in the 
echocardiography clinic. Confidentiality of all information was maintained. 
 
The data capture form did not collect patient’s personal or unique identification 
information and patient confidentiality was maintained. Only the researcher who 
is a medical specialist had access to all the patients’ relevant documents. Once 
the data was entered into the data capture tool for processing; only the allocated 
numbers identified the patients and their characteristics. 
 
2.7 Eligibility Criteria 
All new patients above the age of 18 years that were referred to the 
echocardiography clinic for initial assessment were included in the study. Those 
patients who declined participation or were too sick to give verbal consent on 
their own were excluded. Other emergency or urgent patients who had been 
assessed initially in the wards with a portable echocardiography machine and 
were now sent or referred to the echocardiography clinic for further assessment 
or verification of echocardiography findings were also excluded from the study.  
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Patients who attended for repeat or follow up echocardiograms were also not 
eligible for this study even if they had been lost to follow-up. 
 
2.8 Study Sample 
All new patients referred to the echocardiography clinic from the CHBAH referral 
network during July 2015 and who met the eligibility criteria were included in the 
study. 
 
2.9 Pilot study 
The researcher piloted the data collection sheet with the new patients coming to 
the clinic in June 2015.  
This pilot study assisted the researcher to: 
 ensure that the patients understood the information sheet prepared for the 
study;  
 ensure that the clinic staff i.e. clerks and nursing staff also understood the 
study and where able to explain to patients when asked to clarify; 
 ensure that the nursing staff were adequately trained to get the patients to 
sign the informed consent forms when they came for blood pressure and 
other basic checkups; 
 assess time taken to complete the data collection sheet (Appendix 6), getting 
information to complete the echocardiography request form (Appendix 4) and 
echocardiogram report (Appendix 5); 
 assess time required for completion of data capture of each data collection 
sheet into Microsoft Excel to enable future planning for data entry as the 
study progressed; and  
 decide whether to discard or shorten some responses, thereby reducing the 
time required for fieldwork. 
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Only minor revisions were made to the data collection form.  
2.10  Data collection 
Prior to commencement of fieldwork, the researcher set up a meeting at the end 
of June 2015 with the staff at the echocardiography clinic of the CHBAH to 
reiterate the purpose of the study, the process to be followed in conducting the 
study and to enlist their support. The researcher explained that all new patients 
referred during July 2015 would constitute the study sample. The researcher also 
rotated through the echocardiography clinic and provided clinical care to patients, 
and used this opportunity to explain the study to other medical colleagues who 
were on duty at the echocardiography clinic during the study period.  
 
The first step involved the identification of new patients to the clinic. This was 
done initially by porters who brought patients to the clinic from the wards, and 
these new patients were red flagged for inclusion in the study. Also upon 
registration with the clerks all new patients were identified and given the 
information sheet for the study. The clerks would also explain to these patients 
about the study during the registration process. 
 
Patients were then given the opportunity to read the information sheet as they 
waited for the nursing staff to collect their vital information. The second step 
involved getting informed consent from the new patients by the clinic nurses 
during the collection of their vital studies i.e. blood pressure, pulse, weight, etc. 
This was also an opportunity for the patients to clarify any concerns they had in 
the privacy of the nurses’ consultation area. Patients were required to sign the 
consent form (Appendix 3) with the nurse and a witness was required for those 
who gave verbal consent but could not sign the form for various reasons.   
 
Once consent was obtained, the patients waited for their medical consultations 
and their echocardiograms. Each doctor completed the echocardiography report 
forms in duplicate. The first copy would normally be stapled into the patient file 
and the duplicate filed in the clinic by the clerks. The doctors performing the 
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examinations were asked to collect the consent forms, echocardiography 
requests and then attach them to the duplicate, which would then be filed. At the 
end of each clinic, the clerks were required to make copies of these duplicate 
echocardiography reports and then file both the original documents as well as the 
copy with the consent form and echocardiography request form for each patient 
in a separate study file.  
 
At the end of each week the researcher collected all echocardiography forms and 
requests from the study file, and completed the data collection sheet for each 
patient (Appendix 6). He also classified each echocardiography request as 
appropriate, inappropriate or uncertain according to the 2011 AUC criteria 
(Appendix 7) on the data collection form. Where multiple echocardiography 
indications could be applied, the indication with the strongest level of 
appropriateness was selected. However, some patients did not have clear 
indications for echocardiography and also lacked other pertinent clinical 
information as documents were lost or were not appropriately completed for 
various reasons, and these patients were excluded from the final analysis. Figure 
2.10.1 summarizes the approach to data collection used in the study. 
 
21 
 
 
Figure 2.10.1: Summary of data collection and processing  
 
 
All New Patients 
identified 
n=276 
Consent granted 
n=274 
Echocardiography 
done by Cardiologists 
and Fellows 
Echo report, Echo 
request and consent 
filed in study file  
Researcher collected Echo 
requests and reports and 
completed data capture 
form  
 
Researcher verified 
completeness of 
reports from attending 
physicians where  
necessary 
Data entered onto 
Microsoft Excel and 
analyzed with Minitab 
Version 16 
No Consent granted 
n=2 
Echocardiography 
done and patients 
discharged  
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2.11   Data Analysis 
All data were collected and kept in a safe storage area, and once all the data had 
been collected it was entered into a Microsoft Excel spreadsheet for processing, 
and the spreadsheet was uploaded to Minitab version 16 for analysis.  
 
Descriptive analysis included the calculation of numbers, means and frequencies 
of some of the following patient characteristics; 
a. Demographic information - age, sex, and race, etc. 
b. Diagnoses, presenting symptoms, referral information 
c. Clinical indications for echocardiography 
d. Echocardiography laboratory assessment  
e. Referral (e.g. health professional category of referring person, type of facility, 
etc.) 
f. Appropriateness of referral according to the AUC 
Multivariate analysis was also done to determine whether some of the socio-
demographic variables affected the appropriateness of referral and use of 
echocardiography. 
 
2.12    Study Limitations and Remediation 
This data collection was limited to the month of July 2015 and the new patients 
that were referred and presented on their booked day for echocardiography 
during this time. The selection of one month might have introduced bias, as 
seasonal variations could not be taken into account. However, July is not an 
unusual month for referrals to the echo clinic and some of the patients had been 
booked months earlier for their echocardiograms. Furthermore, the selection of 
the month was influenced by study approval processes, logistics and budgetary 
considerations.  
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The AUC have not been validated or used in a resource-limited African setting 
with a different disease profile, health infrastructure, level of resources, and 
social context to the USA. HIV and its related cardiac disease and its treatment 
complications are more common in the South African environment, and no 
specific criteria addressing this specific group of people have been developed 
and included in AUC. Although this study begins to address the gap of the AUC 
in a resource-limited hospital environment, further research is needed to adapt 
the criteria and to develop a more inclusive tool for resource limited settings.  
 
Another source of ascertainment bias was introduced by the researcher 
assessing the appropriateness of referral using the criteria, especially in patients 
who had missing information, and echocardiography indications had to be 
inferred from the clinical history in the absence of explicitly stated indications. A 
different researcher might have reached a different clinical assessment. To deal 
with this bias, the researcher excluded those patient records with insufficient 
information from the analysis. Furthermore, the researcher who has the skills as 
a cardiology fellow is the only person who assessed the appropriateness of 
referrals, thus reducing inter-assessor variation.   
 
The limitations of the use of medical records included the following: 
 Incomplete records and inability to communicate with referring medical 
personnel to get clarity as some of the patients were referred from more than 
four months ago for echocardiograms, and their clinical conditions might have 
either improved or deteriorated during the waiting period. So the initial 
echocardiography indication might have changed. 
 Illegibility of writing or failure to obtain good copies of echocardiography 
reports if the duplicates were of a poor quality. 
The sample size also limited the type of analysis that could be done in the study 
as it was difficult do multiple logistic regression analysis because of the small 
number of inappropriate referrals found in the study.  
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However, the study has numerous strengths. It was the first study to focus on 
echocardiography appropriate use at CHBAH and in South Africa. Its findings will 
provide a basis for future research on AUC and on the possible revision of the 
criteria used in the tool for resource-limited settings. The study findings will also 
assist with the training of medical staff in the hospital on AUC, and help them to 
reflect on referral practices, and quality of information included in the referral 
forms.  
 
All ethical guidelines were followed and the researcher took specific steps to 
minimize bias. The researcher reviewed the echocardiography requests and 
echocardiography reports and did the data entry to ensure data quality to limit 
individual variability.  
 
The results of the study are discussed in the next chapter. 
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CHAPTER 3: RESULTS 
 
3.1  Introduction 
In this we study recruited 274 participants with only 2 patients refusing to be part 
of the study; hence a 99.3% response rate was obtained. Clinical 
echocardiography indication information was missing from four records. These 
records were excluded from the final analysis. Hence the final sample for 
analysis was 270.  
 
3.2  Demographic and social profile  
The majority of the study participants 63.1 % (n=173) were women, and 88.3% 
(n=242) black African (Table 3.2.1). The mean age of patients was 53.2 years 
(SD ±16.6) years. The mean age of female patients was 53.9 (SD ±17.0) years 
and for males 51.9 (SD ±16.0) years. Table 3.2.1 shows the socio-demographic 
profile of all the new patients referred to the echocardiography clinic for the study 
period and included in the study.  
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Table 3.2.1: Socio-demographic characteristics of the study participants 
Characteristic Female Male Total 
Number (%) 160 (63.1) 100 (36.9) 260 (10 missing 
Gender) 
Mean age (Standard 
Deviation) 
53.93 (17.0) 51.91 (16.0) 53.2 (16.6) 
Age group (%) 
<20 years   11 (4.1) 
21-30 years   20 (7.5) 
31-40 years   30 (11.2) 
41-50 years   41 (15.4) 
51-60 years   69 (25.8) 
61-70 years   58 (21.7) 
71-80 years   29 (10.9) 
>80 years   9 (3.4) 
    
Race     
Black African (%) 154 (63.6) 88 (36.4) 242 (88.3) 
Coloured (%) 3 (60.0) 2 (40.0) 5 (1.8) 
Indian (%) 4 (66.7) 2 (33.3) 6 (2.2) 
White  12 (57.1) 9 (42.9) 21 (7.7) 
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3.3  Clinical profile of new echocardiography patients 
3.3.1 Clinical diagnosis 
Before referral to the echocardiography clinic the treating clinicians evaluated 
patients and reached a clinical diagnosis on which they based their referral.  
 
The most common clinical diagnosis in the study population was hypertension 
with 123 (44.5%) of the patients having hypertension as one of their clinical 
diagnosis, followed by congestive cardiac failure in 60 (22.2%) of the patients. 
Pre-chemotherapy patients referred for baseline echocardiography were 27 
(10.0%). Only 12 (4.4%) patients were referred for suspected valvular heart 
disease and only 29 (10.7%) retro-positive patients had their HIV status 
documented on the request form. Table 3.3.1 shows the documented clinical 
diagnosis on the echocardiography request forms. The clinical diagnoses 
(n=499) exceed the number of patients (n=270) as some patients had more than 
one clinical diagnoses recorded. However, the percentages in Table 3.3.1 are 
expressed on the total number of patients. 
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Table 3.3.1: Clinical Diagnoses recorded * 
Clinical Diagnosis Count % 
Shunt? ASD/VSD 1 0.4 
Anemia 7 2.6 
Arrhythmia 8 3.0 
Atrial Fibrillation 18 6.7 
Cancer for Chemotherapy 27 10.0 
Cardiomyopathy 21 7.8 
Congestive Cardiac Failure (CCF) 60 22.2 
Chronic Kidney Disease 24 8.9 
Congenital Heart Disease 1 0.4 
Connective Tissue Disease 15 5.6 
Chronic Obstructive Pulmonary Disease (COPD) 13 4.9 
Coronary Syndrome 20 7.4 
Cerebrovascular Accident (CVA) 19 7.0 
Diabetes 30 11.1 
Exclude cardiac disease 3 1.1 
Gangrene? Embolic Phenomena 8 3.0 
Heart Block 3 1.1 
Hypertension 123 45.6 
Metabolic Syndrome 5 1.9 
Pericardial Disease 4 1.5 
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Clinical Diagnosis Count % 
Postpartum Cardiomyopathy 4 1.5 
Pulmonary Hypertension 30 11.1 
Retroviral Disease 29 10.7 
Valvular Heart Disease 12 4.4 
Other 14 5.2 
Total 499 100 
* One patient could have more than one clinical diagnosis  
 
From Table 3.3.1 above the most common indication for echocardiogram was 
indication #67 “Initial evaluation of suspected hypertensive heart disease”. 
However at presentation to the echocardiography clinic the systolic BP was 
132.4 mmHg and the diastolic blood pressure of 83.1 mmHg and a pulse rate of 
86.0 bpm. These patients had already been started on treatment in the ward or 
from the referral clinic. The average waiting time from echocardiography booking 
and presentation to the echocardiography clinic was 6.6 days for inpatients and 
8.0 days for outpatients. The echocardiography clinic recorded blood pressures 
were done when most of the patients had been on treatment for at least 5 days. 
 
3.3.2  Echocardiogram assessment 
Upon completion of the echocardiograms the cardiologists and fellows were able 
to make a definitive echocardiogram assessment in 267 patients. Since some of 
these patients had multiple comorbidities, a total of 308 echocardiography 
assessments were done. The remaining seven patients were either referred for 
repeat studies or TEEs or were to be followed up by the senior consultants in the 
unit for verification of echocardiography findings before an assessment was 
made. Table 3.3.2 summarizes the final echocardiography assessments.  
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Table 3.3.2:  Echocardiographic Assessment 
Echocardiographic Assessment Count 
% 
Atrial Fibrillation with Rapid Ventricular Response 5 1.9 
Aortic Valve Disease 11 4.1 
Cardiomyopathy 51 19.1 
Cor-Pulmonale 17 6.4 
Coronary Syndrome 5 1.9 
Good LV Systolic Function 6 2.3 
Hypertensive Heart Disease 111 41.6 
Mitral Valve Disease 10 3.8 
Myocarditis 1 0.4 
No Cardio-embolic Source found 1 0.4 
Normal Study 60 22.5 
Pericardial Disease 8 3.0 
Post-partum Cardiomyopathy 2 0.8 
Pulmonary Hypertension 18 6.7 
Rheumatic Heart Disease 1 0.4 
Shunt ASD/VSD 1 0.4 
Total unique echocardiography assessments 308 100 
Total number of patients with echocardiography 
assessments 
270  
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Hypertensive heart disease was diagnosed in the majority of patients being 
41.6% (n=111). Normal studies were found in 22.5% (n=60) of the referred 
patients, majority of whom were young mostly HIV positive patients being worked 
up for cancer chemotherapy and they were 27 in total. Excluding all 27 pre-
chemotherapy patients from the 60 normal studies would still leave 10.7% (n=33) 
patients with normal hearts which means that these patients had not been 
properly assessed clinically before being referred for echocardiogram. 51 
patients (19.1%) had a cardiomyopathy and only one patient (0.4%) was 
diagnosed with rheumatic valvular heart disease. 
 
3.4 Appropriateness of referral 
The majority of referrals (93.3%) were appropriate according to the AUC, 3.7% 
(n=10) patients were inappropriately referred and 3.0% (n=8) patients had 
uncertain indication for referral Among the 252 appropriate referrals, the majority 
66.3% (n=179) were rated 9, indicating a strong indication for echocardiography 
with the rest being rated 8 (27.0%, n=73) (see Table 3.4.1 below). 
 
Table 3.4.1: Referral Appropriateness 
Appropriateness AUC Score Count Percentage 
Inappropriate 2 10 3.7 
Uncertain 6 8 
3.0 
Appropriate Referral (weak 
indication) 
8 73 27.0 
Appropriate Referral (strong 
indication) 
9 179 66.3 
Total 
 
270 
 
 
 
32 
 
Comparing the referral site or clinics from where patients were referred from, the 
results show that, there were 95.3% appropriate referrals from inpatient wards at 
CHBAH, for example the medical and surgical wards, compared to 75% 
appropriate referrals from other specialist clinics within the hospital like the 
diabetic, rheumatology, medical outpatients and surgical outpatients or other 
private doctors and surrounding hospitals. This analysis was based on 85 
inpatient referrals and 16 outpatient referrals that had documented referral site. 
 
3.4.2 AUC used in study 
The 2011 AUC has a total of 98 indications for transthoracic echocardiography. 
In this study only 19 of the 98 were used for this population, meaning that the 
other 79 indications did not apply to the specific circumstances or environment in 
which we treat our patients. For example from the categories in Table 1.4.1, 
category 4 dealing with ventricular assist devices and cardiac transplantation 
does not apply at CHBAH because the hospital did not supply ventricular 
assistive devices and was not performing  heart transplantation in 2015.  
More importantly in this study population the indications used are listed in Table 
3.4.2 below. The most common appropriate indications were, (2011 AUC 
indication #67, score 8): “Initial evaluation of suspected hypertensive heart 
disease” (23.7% n=64) and (2011 AUC indication #70, score 9); “Initial evaluation 
of known or suspected HF (systolic or diastolic) based on symptoms, signs, or 
abnormal test results” (21.9 % n=60).  Appendix 7 gives a full list of the 2011 
AUC for echocardiography.  
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Table 3.4.2: TTE Indications According to 2011 AUC 
 
AUC  Score Indication description Count (%) 
1 9 Symptoms or conditions potentially related to 
suspected cardiac etiology including but not limited 
to chest pain, SOB, palpitations, TIA, stroke, or 
peripheral embolic event. 
24 (8.8) 
5 9 Sustained or non-sustained atrial fibrillation, SVT 
or VT 
8 (2.9) 
6 2 Asymptomatic isolated sinus bradycardia 1 (0.4) 
7 9 Clinical symptoms or signs consistent with a 
cardiac diagnosis known to cause light-
headedness/pre-syncope/syncope (including but 
not limited to aortic stenosis, HCM or HF) 
5 (1.8) 
10 2 Initial evaluation of ventricular function (e.g., 
screening) with no symptoms or signs of 
cardiovascular disease 
5 (1.8) 
13 2 Routine perioperative evaluation of ventricular 
function with no symptoms or signs of 
cardiovascular disease 
2 (0.7) 
14 6 Routine perioperative evaluation of cardiac 
structure and function prior to non-cardiac solid 
organ transplantation 
8 (2.9) 
15 9 Evaluation of suspected pulmonary hypertension 
including evaluation of right ventricular function 
and estimated pulmonary artery pressure 
29 (10.6) 
22 8 Evaluation of a patient without chest pain but with 
other features of an ischemic equivalent or 
laboratory markers indicative of ongoing MI 
10 (3.6) 
28 2 Suspected pulmonary embolism in order to 
establish diagnosis 
1 (0.4) 
34 9 Initial evaluation when there is a reasonable 
suspicion of valvular or structural heart disease 
9 (3.3) 
59 9 Suspected pericardial conditions 3 (1.1) 
60 2 Routine surveillance of known small pericardial 
effusion with no change in clinical status 
1 (0.4) 
63 9 Evaluation of the ascending aorta in the setting of 
a known or suspected connective tissue disease or 
genetic condition that predisposes to aortic 
aneurysm or dissection (e.g., Marfan syndrome) 
1 (0.4) 
67 8 Initial evaluation of suspected hypertensive heart 
disease 
64 (23.4) 
70 9 Initial evaluation of known or suspected HF 
(systolic or diastolic) based on symptoms, signs, or 
60 (21.9) 
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AUC  Score Indication description Count (%) 
abnormal test results 
86 9 Initial evaluation of known or suspected 
cardiomyopathy (e.g., restrictive, infiltrative, 
dilated, hypertrophic, or genetic cardiomyopathy) 
14 (5.1) 
91 9 Baseline and serial re-evaluations in a patient 
undergoing therapy with cardiotoxic agents 
23 (8.4) 
92 9 Initial evaluation of known or suspected adult 
congenital heart disease 
2 (0.7) 
No   4 (1.5) 
Total   270 
 
There were four patients that could not be classified according to the 2011 AUC 
criteria and were excluded from the study. 
 
Patient 1 was a 55-year-old female who was found to have cardiomegaly on 
chest X-ray and symptomatic anemia that was referred from the Medical 
Outpatients Department. No other clinical information was given on the request. 
However, the subsequent echocardiography showed a structurally normal heart. 
 
Patient 2 was a 52-year-old male with a history of being on steroids and 
methotrexate. Clinically he was cushingoid from the steroids and had a history of 
having bullous lung disease. He was referred from an inpatient ward and the 
echocardiography showed a normal heart. 
 
Patient 3 was a 22-year-old female being investigated for lupus and had bilateral 
pleural effusions referred from an inpatient ward. The echocardiography however 
showed a pericardial effusion and normal systolic function and the cardiologist’s 
impression was that of a possible lupus related serositis. 
 
Patient 4 was a 56-year-old female who was diagnosed with a possible myotonic 
dystrophy and an echocardiography was requested to rule out cardiac 
involvement. ECG was normal and the patient had a murmur at the apex. 
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Echocardiography, however, revealed a pericardial effusion with fibrinous strands 
suggestive of a TB pericarditis. 
 
3.5 Relationship between socio-demographic profile and appropriateness 
of referral 
From Table 3.4.1 3.7% n=10 patients were inappropriately referred for 
echocardiogram and 3.0% (n=8) patients had uncertain indications for 
echocardiograms. This small sample precludes a more detailed analysis of the 
relationship between socio-demographic profile and appropriateness of referral. 
 
Out of the total population of 270 with referral indications only 263 had the 
patients age documented on their echocardiography requests or 
echocardiography report form. Figure 3.5.1 below shows the referral 
appropriateness according to patient age. 
 
 
Figure 3.5.1: Referral appropriateness according to patient age 
 
From the Figure 3.5.1 above, inappropriate referrals were mainly in the younger 
ages and uncertain indications for echocardiogram showed no relationship with 
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patient ages, whereas there is a discernable normal distribution of weakly 
appropriate and strongly appropriate indications for echocardiogram for this study 
population. 
 
3.6 Profile of inappropriate referrals  
A total of 10 patients were referred inappropriately: these were young patients 
ranging from 17 years to 51 years with a mean age of 31 years. Of these 
inappropriate patient referrals, 80% (n=8/10) of the patients had normal 
echocardiograms. Some of the common clinical diagnoses in the group include 
retroviral disease and connective tissue disorders. A clinical profile of the 
inappropriately referred patients is provided in Appendix 8. 
 
The next chapter will discuss the study findings in light of existing literature and 
explore the implications of this study. In chapter 5 appropriate recommendations 
are highlighted as well as possible areas for further investigation. 
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CHAPTER 4: DISCUSSION 
 
4.1  Introduction  
Worldwide there is noticeable trend towards the greater use of technology for 
clinical diagnosis. Echocardiography is a useful diagnostic tool, which if 
appropriately utilized can contribute to enhanced diagnosis and lifesaving 
treatment of patients. On the other hand, potential abuse of echocardiography in 
a resource-limited setting may prejudice those patients who genuinely require 
echocardiography for continued management of their cardiovascular conditions. 
Also, there is the competing cost of performing echocardiography, both on the 
patients and the health care system. This necessitates that patients coming from 
home for echocardiography or referred from other hospitals are appropriately 
referred and the opportunity is well utilized. 
 
This research study explored the appropriateness of referrals to the 
echocardiography clinic at CHBAH. The remainder of the chapter discusses the 
findings in light of the study objectives, and the existing literature. 
 
4.2 Socio-demographic profile 
The mean age of the CHBAH study population was 53 years, which is lower 
compared to other similar studies. A study at a teaching hospital in Lebanon had 
a population with a mean age 65 (Rameh and Kossaify, 2016).  Furthermore, the 
Lebanese study population was predominantly male (59.3%), whereas this 
CHBAH study population was predominantly female (63.1%) This younger study 
population at CHBAH may be due to the extra burden imposed by HIV - related 
cardiovascular diseases and malignancies in young people. This suggests that 
echocardiography for diagnosis and as an adjunct to chemotherapeutic 
monitoring may become a necessity in younger people. For example, in our 
study we had some very young patients who were born with HIV, and are now in 
their late teens and presenting for assessment of HIV-related malignancies. In 
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our study, only 10.7% of the patients had an HIV positive status recorded on the 
request form. This may be because HIV remains highly stigmatized among the 
CHBAH patient population, or that it was an oversight on the part of clinicians by 
not recording the HIV status of the patients. 
4.3 Clinical profile 
Clinical Diagnosis 
Hypertension was the most common clinical diagnosis in this population, with 
45.6% of patients being diagnosed with it. This highlights the importance of 
screening for, and treating hypertension in this population from a young age. This 
is also highlighted further by the fact that some of the other common clinical 
diagnoses like congestive cardiac failure 22.2% (n=60), chronic kidney disease 
8.9% (n=24), cerebrovascular disease 7.0% (n=19) and atrial fibrillation 6.7% 
(n=18) are hypertension-related (see table 3.3.1). Diabetes, the other common 
NCD, was found in 11.1% (n=30) of the patients. Hypertension and diabetes 
have been well described in this population and their economic effects are well 
elucidated (Hofman, 2014). 
 
The other major clinical problem in the CHBAH population is HIV and 29 patients 
(10.7%) had an HIV positive status documented on their echocardiography 
request form. South Africa has the biggest population of HIV positive individuals 
in sub-Saharan Africa, estimated to be around 6 million people living with HIV 
(Statistics South Africa, 2016). The country also has the largest HIV treatment 
program in the world improving life expectancy in this population. A variety of 
cardiac lesions have been reported in HIV infection and AIDS, including 
pericardial disease with effusion and tamponade, nonspecific or infectious 
myocarditis, dilated cardiomyopathy with global left ventricular dysfunction, 
endocardial valvular disease due to marantic or infective endocarditis, 
arrhythmias, pulmonary hypertension and neoplastic invasion (Sani et al., 2005). 
In this treatment era, coronary artery disease and dyslipidemia, drug related 
cardiotoxicity and cardiac autonomic dysfunction are becoming increasingly 
prevalent. (Sani et al., 2005).  
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The 2011 AUC echocardiography do not adequately address the specific HIV 
and heart disease related indications for echocardiography in a high prevalence 
region like sub-Saharan Africa. These current criteria were developed before the 
current massive HIV rollout programs, when there was a lot of focus on HIV 
prevention and early treatment. Now more work needs to be done to target early 
detection and treatment of HIV related cardiac disease and echocardiography is 
useful in this regard. Specifically, in our study we had HIV positive patients with 
normal hearts being referred for echocardiography, with no other specific cardiac 
indications suspected besides the HIV diagnosis.   
 
Using the most appropriate clinical diagnosis in each patient the major indication 
for echocardiography was indication #67 “Initial evaluation of suspected 
hypertensive heart disease”, 23.4% (n=64) - see Table 3.4.2.  
 
Echocardiographic Assessment 
Hypertensive heart disease was confirmed in 41.6% (n=111), of patients who had 
an echocardiographic assessment done, while 45.6% (n=123) had been 
diagnosed with hypertension clinically.    
 
60 patients had normal studies (22.5%) in total, and of these, 33 patients (12.2%) 
had normal hearts after excluding the cancer patients. Of the total study 
population this means that 12% of patients actually had normal studies, which 
mean these studies were not indicated in this group of patients. This again 
highlights the importance of clinical assessment of patients prior to requesting 
echocardiograms. From a healthcare utilization and cost perspective, this 
represents a non-sustainable situation, as already we have a lot of hypertension 
testing and screening algorithms which should assist us in using the least costly 
diagnostic test. Unfortunately, hypertension is an asymptomatic condition until it 
manifests with complications by which time, most of the cardiovascular changes 
may be irreversible and therefore more costly to treat. 
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The fact that only one new patient was diagnosed with rheumatic valvular heart 
disease also highlights the changing disease profile from infective diseases to 
NCDs such as hypertension and diabetes. This shift also highlights the improved 
living conditions, the success of the treatment of rheumatic fever during 
childhood, and improved access to health care services. 
 
4.4  Referral Appropriateness 
The 2011 AUC criteria can be successfully applied in this patient population as 
98.5% of echocardiogram requests could be classified according to them. 
However, from Table 3.4.2 out of the 98 criteria only 19 were used in this study, 
suggesting that an abbreviated list of criteria will be able to adequately cover the 
majority of indications in a similar population or health care setting. This 
abbreviated list will however, have to be adjusted as the services at CHBAH 
increase to cover new services likely to be introduced, such as the use of left 
ventricular assist devices and heart transplantation. In their study in Lebanon, 
Rameh and Kossaify (2016) utilized 34 criteria for their study population and 
other studies have utilized a higher number of indications commensurate with 
their services provided. 
 
Overall 93.3% (n=252) of all participants were referred appropriately, however 
the echocardiograms revealed a high number of normal studies even after 
excluding patients being assessed for cancer chemotherapy initiation. This 
suggests that there may be a disconnect between making the request and the 
actual clinical condition of the patient. Some of the reasons may be because 
clinicians are not assessing patients properly due to time constraints, staff 
shortages or declining clinical skills. From the results, inpatient wards had 95.3% 
appropriate referrals compared to 75% from the clinics. This may be due to the 
fact that in the wards, patients are being assessed at the least by an intern, a 
registrar and a consultant first before the echocardiogram is requested, whereas 
in the clinics junior staff may request echocardiograms without necessarily 
discussing with senior colleagues who may not always be available.    
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In addition, as discussed above 80% (n=8) of the inappropriate referrals had 
normal echocardiograms which may suggest that they were inappropriate 
requests or the need to educate clinicians on the use of echocardiography. It 
may be reassuring though that in comparison with global trends the overall 
inappropriate request ratios are lower compared to other settings. For example, 
in their 2012 study in a community setting in the USA, Ballo et al had 14.7% 
(n=135) inappropriate requests (Ballo et al., 2012). In the 14 Welsh hospital study 
including two tertiary centers in 2012, the authors also had 11% (n=115) 
inappropriate requests (Gurzun and Ionescu, 2014). Our relatively lower 
inappropriate request rate may simply be due to the fact that CHBAH is a tertiary 
center, and the majority of patients are very sick due to their late presentation for 
care, whereas in countries with better functioning healthcare systems, patients 
are screened earlier and present for care at an early stage.    
 
4.4.1  Why are so many patients with normal results referred? 
In a high volume hospital like this where the average daily medical intake is 
about a 120 patients the inappropriate normal requests may also signify a 
reliance on technology to assess patients as interns will admit an average of 20 
patients each every five days for investigation and management. On the intake 
day, some of these patients may not be assessed properly. Unfortunately, as 
technology advances, clinicians may become more and more reliant on it. For 
example, at CHBAH, the protocol is that Interns have to assess intake patients 
clinically under the supervision of registrars. The registrars, interns and medical 
officers are then supervised by a consultant in the assessment and management 
of patients on the post-intake day. However, since CHBAH is the busiest hospital 
in South Africa, this system does not always work in practice because of staff 
shortages, work space limitations, and other systemic issues which preclude 
proper clinical review. Being a teaching hospital as well, some consultants may 
focus more on the teaching and provide less patient-specific clinical input during 
their rounds. And the majority of clinicians are not comfortable interpreting some 
clinical signs suggestive of cardiac disease, and so they use echocardiography 
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as a safety net in case they missed important findings clinically. So, reliance on 
technology in such a high output teaching hospital is common.  
  
4.4.2 Comparison with other parts of the world  
Since CHBAH is a large tertiary teaching facility with a large referral network one 
can assume that by the time patients are referred to this facility they will have 
already been screened at the clinics, other referring hospitals, casualty 
department and will have at least been assessed by a nurse, medical officers or 
more senior category of medical professional. These multiple assessments at 
different levels help to reduce the number of patients inappropriately referred to 
CHBAH. In other studies, with similarly high referral appropriateness in America, 
the majority of requests were done by cardiologists or specialist physicians and 
inappropriate referrals from such highly skilled professionals were partly 
explained by the practice of defensive medicine, and the different funding models 
of health care which incentivizes the utilization of certain services (Ballo et aI., 
2012). To limit the overuse and abuse of echocardiography in the USA, referrals 
were linked to some form of reimbursement, which would not pay for 
inappropriate studies mandating the need to appropriately screen patients before 
requesting echocardiograms.  
 
4.5  Relationship between socio-demographic profile and 
appropriateness of referral. 
In this study, only ten patients (3.7%) were inappropriately referred for 
echocardiogram and at least 50.0% of them were 30 years or younger. From the 
narrative in section 3.5 in this group, retroviral disease and connective tissue 
diseases comprise the commonest diagnoses in this patient category. The fact 
that 80% of these patients had normal echocardiograms suggests that they were 
inappropriately referred initially. The younger age group suggests that 
inappropriately referred patients tend to be younger. In fact, the youngest patient 
in this study was a 17-year-old female who was referred inappropriately. This 
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implies that before being considered for echocardiography young people may 
need to meet more stringent criteria.   
 
There was a trend of improved appropriateness with increasing age in our study 
population (Figure 3.5.1). This is consistent with natural aging as lifestyle 
diseases manifest with age. Improved survival into the 70s and 80s mean that 
more people are diagnosed with cardiovascular diseases as they get older. This 
finding is consistent with other parts of the world. Improved population survival 
means an increase in cardiovascular disease burden with its associated high 
mortality.  
 
Unfortunately, in this study we were not able to do more robust analysis of the 
inappropriately referred patients due to the small sample population. 
 
4.6 Limitations  
This is a single center study carried out by a single investigator and the results 
may be different if the clinical indications for echocardiography is interpreted by 
another fellow or consultant cardiologist, or the study is carried out in another 
institution. For example, we have a very large hematology service and a large 
renal service and a lot of their patients require screening echocardiograms before 
chemotherapy or chronic renal dialysis respectively, which may not be the same 
in other institutions. Also, this study does not address the clinical impact of the 
echocardiography findings, which is the true measure of the true appropriateness 
of a diagnostic imaging study (Ward et al., 2008). 
 
Interns, medical officers, registrars and consultants making use of this service 
have not had any formal training on the utility of echocardiography, so some of 
the inappropriate requests or the discordance between clinical request and 
echocardiography findings may be different in another setting with a more 
homogenously trained staff or with stricter referral protocols. Also in a less busy 
hospital setting where treating clinicians have time to adequately assess patients, 
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this may result in less echocardiography requests and more appropriate referrals 
being made.  
 
As mentioned above this was a sample of patients presenting in a specific 
month, so choosing a different month may have yielded a different result. 
However, despite this, useful lessons have been learnt on which future studies 
can be based on. Firstly, we have set a baseline on which future studies in 
similar resource limited settings can benchmark their services. The fact that only 
one patient was diagnosed with a new rheumatic valvular lesion confirms the fact 
that South Africa is in a transition from infectious diseases to NCDs. This shift 
demands a specific health system response resulting in changes in resource 
allocation and training to tackle the socioeconomic effects of NCD’s. The 
abbreviated AUC identified in this study is a useful initial step in developing 
guidelines and AUC appropriate to South Africa and other LMIC’s. And finally the 
fact that in this study we achieved similar results to studies elsewhere contributes 
to the validity of the use of AUC in our setting.  
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CHAPTER 5: CONCLUSIONS AND RECOMMENDATIONS 
 
5.1 Introduction 
Using a cross-sectional study design, this study sought to investigate the 
appropriateness of referrals to the echocardiography clinic at CHBAH, a busy 
large tertiary care hospital. The study generated locally context-specific 
information on the socio-demographic profile of patients referred; the clinical 
profile of patients; and the appropriateness of referral.  
The study findings confirm that the current practice of echocardiography referrals 
at the hospital are in line with the practice in other parts of the world. However 
they also raise the specific population need of providing a quality HIV 
cardiovascular service in response to the increased survival and higher 
cardiovascular risks of this population due to HIV/AIDS and its treatment. Already 
there are 6 million people with HIV and a growing number on treatment in South 
Africa, hence these people have to access quality cardiovascular services at 
some point either for prevention or treatment.  
 
The government of South Africa has identified NCDs as a key health focus area 
going forward, and cardiovascular disease and cancer care are the two highest 
cost drivers for the health care system. Implementing protocols and practices that 
maximize efficient use of available resources is important in achieving universal 
coverage with comprehensive health services.    
  
5.2  Recommendations 
As a consequence of this study the following are the recommendations. 
 
Appropriateness of referral 
 Use of abbreviated indications will capture the majority of need for TTE in this 
population, so there is a need to develop a local protocol based on the 2011 
AUC criteria. An abbreviated list will be easier to train clinicians on. 
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 Due to the high burden of HIV/AIDS there is a need to incorporate HIV 
disease specific indications in this area with a high prevalence of HIV and 
other infective diseases. So, clear indications for screening and diagnosis of 
HIV related cardiac disease have to be developed in this regard. 
 
Clinical Profile 
 There is a greater need to suspect and screen for hypertension in this 
population as a significant number of people are found to have 
echocardiographic features of hypertensive heart disease in those who report 
being hypertensive. Better utilization of current screening and diagnostic 
algorithms should be emphasized at all levels of the healthcare system 
 Need to create a dedicated service for HIV patients with cardiovascular 
diseases for further research purposes, and build relevant skills as part of 
improving the national HIV program. There is a need to understand 
accelerated cardiovascular disease in the context of HIV with a view of 
creating strategies to slow this disease progression. 
 
Health care workers 
 Share the results of this study with healthcare workers to stimulate debate on 
appropriate referrals 
 Need to train clinical staff on proper clinical assessments and utility of 
appropriate referrals 
 Administrative staff should be trained on the importance of collecting the 
prescribed social and demographic information from patients. 
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Hospital Level Recommendations 
 Improve the quality of record keeping, especially a reduction in missing 
information in some of the reports. The hospital quality assurance teams 
should carry out audits in the wards and specialist clinics to ensure accurate 
completion of patient documents and appropriate and correct filing.  
Policy level  
 Current clinical guidelines used in echocardiography should be widely 
communicated, and the amendment and adoption of appropriate use criteria 
specific to this environment done to monitor and ensure that all facilities 
perform within agreed norms. Where problems are identified, strategies 
should be developed to promptly correct the practice. 
 The state should also ensure that cardiac services are able to cope with the 
expected rise in demand due to changing disease profile, hence the need to 
measure appropriate use with a view to planning for future expansion of 
services. 
5.3 Conclusion 
This study has generated new knowledge on the clinical appropriateness of 
referrals to the echocardiography clinic at Chris Hani Baragwanath Academic 
Hospital, using the Appropriate Use Criteria 2011 criteria. As already mentioned 
above, this is a large teaching hospital with a large referral network in a resource-
limited community in sub-Saharan Africa. This is a very busy echocardiography 
unit with 270 new patients presenting for echocardiography during the month of 
July 2015. This study is particularly important because it is the first study to use 
these Appropriate Use Criteria indications in sub-Saharan Africa in general, and 
in South Africa in particular. The study findings have public health and policy 
implications, enunciated in the recommendations outlined above. 
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Appendix 2 Patient Information Sheet 
 
Clinical appropriateness of referrals to the echocardiography clinic at the 
Chris Hani Baragwanath Academic Hospital 
 
 
PATIENT INFORMATION SHEET  
 
 
Overall what is this study about? 
 
The study would like to get more information about patients who are sent to the 
echocardiography clinic at Chris Hani Baragwanath Hospital, from other clinics, 
hospitals or doctors. This information includes things like the age of patients, 
where they live, and the reasons for their illness.  
 
How we will find this out? 
 
We would like to collect copies of the echo referral forms and copies of the echo 
reports once the doctors have finished writing them of all new patients coming to 
the clinic for a couple of months. These forms will be collected by the clerks and 
given to the doctor, Dr. Farai Dube. Personal details like your name, surname, 
and hospital number will not be included on each assessment form.   
 
How do I know that the information collected from my records will be kept 
confidential? 
 
Dr. Dube is a medical doctor who is doing specialist studies and he knows the 
importance of patient confidentiality and record keeping principles.  All patients 
will be assigned a code on their completed assessment form, and the 
Investigator will only know this code. All the participants’ assessment forms will 
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be combined and analyzed to look for referral appropriateness and associations. 
No names will be revealed on analysis and report resulting from this study.  
 
Did you get permission to carry out the study? 
 
Permission to carry out this project was obtained from the University of the 
Witwatersrand Research Ethics Committees and the Chris Hani Baragwanath 
Academic Hospital CEO and Research Committee.  We will appreciate your 
participation and we will ask you to sign an informed consent form to participate 
in the study and to let us have a look at your records.  
  
Will there be any benefits from participating? 
 
There will be no direct benefits to anyone who participates in the study, as 
participation is voluntary. This means you have the right to refuse to have your 
information included in the study. But we hope that the study will give us 
important information about the reasons that patients come to this hospital echo 
clinic. 
 
Will there be any harm from participating? 
 
There will be no negative consequences for individuals who do not want to be 
included in the study. However, we would really appreciate it if we could include 
your information as you are using this clinic. We hope that the information we will 
get from you will be used to inform our future referral criteria to this busy clinic.  
 
Who controls this project?   
 
Dr. Dube does this project from the Division of Cardiology at Chris Hani 
Baragwanath Academic Hospital. He is being supervised by a professor at the 
School of Public Health at the University of the Witwatersrand.   
55 
 
 
Who do I contact if I want to ask more questions?  
 
We will be happy to answer any questions you have about this study. The 
University of the Witwatersrand Research Ethics Committee has approved this 
research.  If you have any questions about your rights as a study participant, or 
questions or concerns about any aspect of the study, you may contact Professor 
Cleaton-Jones or the ethics office on (011) 717 1234. If you have questions 
about the research, you may also contact:  
 
Dr. Farai Dube 
Division of Cardiology 
Chris Hani Baragwanath Academic Hospital 
Phone: +27 11-9336275  
Email: faraidube@yahoo.com 
 
Or  
 
Professor Laetitia Rispel 
School of Public Health 
University of the Witwatersrand, Johannesburg 
Phone: +27 11-717 2043 
Email: laetitia.rispel@wits.ac.za  
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Appendix 3 Consent Form 
 
Clinical appropriateness of referrals to the echocardiography clinic at the 
Chris Hani Baragwanath Academic Hospital 
 
CONSENT FORM  
 
I have been given the information sheet on the project entitled: Clinical 
appropriateness of referrals to the echocardiography clinic at Chris Hani 
Baragwanath Academic Hospital. I have read and understood the Information 
Sheet and all my questions have been answered satisfactorily.  
 
I understand that it is up to me as a patient to decide whether or not to participate 
and have my information included in this study. I also understand that there will 
be no negative consequences for my decision.  
 
I understand that the researchers involved in this project will make every effort to 
ensure confidentiality when reporting. I consent to participating in this study. I 
have been given the information sheet with telephone numbers that I may call if I 
have any questions or concerns about the research.  
Patient verbal consent: Yes No 
   Date:  
Patient signature:  Date:  
OR 
Nurses signature:  Date:  
 
Witness’s signature:  Date:  
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Appendix 4 Echo Request Form 
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Appendix 5 Echocardiogram report 
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Appendix 6 Data Collection Sheet 
 
For official use only 
 
1.  Participant number  
  
    
 
Date of referral:   DD/MM/YY 
 
    
  
3. 
 
Date of examination DD/MM/YY     
  
 
 
Record complete 
 ◻Yes…1 
◻ No…0 
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SECTION 1: BACKGROUND INFORMATION 
For official use only 
    
  Gender  ◻ Male…1 
◻ Female…2 
  Age in years 
 
________________ 
 
 
 
 
 
 
 Population group ◻ Black…1 
◻ Coloured…2 
◻ Indian…3 
◻ White…4 
◻ Other…9 
 
 
 Foreign National  ◻ No…0 
◻ Yes…1 
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Referred from  
◻ CHBAH Inpatient…1 
◻ CHBAH Outpatient clinic…2 
◻ Jabulani Hospital and Soweto 
clinics…3 
◻ Natalspruit Hospital…4 
◻ Sebokeng Hospital…5 
◻ Selby Park Hospital…6 
◻ Hiedelburg Hospital…7 
◻ Sebokeng Hospital…8 
◻ Potchestroom Hospital…9 
◻ Private GP’s/Specialists…10 
◻ Other…11 
 
 
 
 
CHBAH Inpatient referral  
◻ Medical Wards…1 
◻ Surgical and Orthopedics 
Wards…2 
◻ Obstetrics and Gynaecology 
wards…3 
◻ Other…4 
 
 
 CHBAH Outpatient referral  
 
◻ MOPD…1 
◻ Med REG…2 
◻ Other Specialist Clinics…3 
◻ Other…4 
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 Referred by  ◻ Intern…1 
◻ Medical Officer…2 
◻ Registrar…3 
◻ Fellow…4 
◻ Consultant…5 
◻ Cardiologist…6 
◻ Other…7 
◻ Not sure…8 
 
 
 Patient follow up post Echo  ◻ Back to referral 
clinic/clinician…1 
◻ Cardiomyopathy clinic…2 
◻ Valve clinic…3 
◻ Congenital clinic…4 
◻ Coronary clinic…5 
◻ Admitted to Coronary Care 
Unit…6 
◻ Admitted to Medical wards…7 
◻ Other…8 
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SECTION 2: CLINICAL INFORMATION 
    
 
 
 Clinical Diagnosis 
 
◻ Hypertension…1 
◻ Valvular Heart Disease…2 
◻ Arrhythmia…3 
◻ Cardiomyopathy…4 
◻ Diabetes…5 
◻ Coronary Syndrome…6 
◻ Retroviral Disease…7 
◻ Pericardial Disease…8 
◻ Nonspecific clinical findings…9 
◻ Infective Endocarditis…10 
◻ Cardiovascular accident 
(CVA)…11 
◻ To exclude heart disease …12  
◻ Other…13 
 
 
 Chest X ray findings noted  
 
◻ Yes …1 
◻ No…2 
 
 
  ECG findings reported 
 
◻ Yes…1 
◻ No…2 
 
 
 
 Blood Pressure and Pulse ________________ 
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SECTION 3: APPROPRIATENESS OF REFERRAL 
For official 
use only 
   
 
 
 
Request  according to AUC 
indications 
________________ 
  Request Appropriateness 
 
◻ Yes…1 
◻ No…2 
◻ Uncertain…3 
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For official 
use only 
   
 
 
 Echocardiographic assessment ◻ Hypertensive Heart Disease…1 
◻ Dilated Cardiomyopathy…2 
◻ Diastolic Dysfunction…3 
◻ Mitral Valve Disease…4 
◻ Aortic Valve Disease…5 
◻ Tricuspid Valve Disease…6 
◻ Pulmonary Hypertension…7 
◻ Congenital Heart Disease…8 
◻ Pericardial Disease…9 
◻ Coronary Syndrome…10 
◻ Infective Endocarditis…11 
◻ Cardio-embolic Source noted…12 
◻ Rheumatic heart disease …13  
◻ Normal Echocardiogram…14 
◻Other …15 
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Appendix 7 2011 AUC Criteria 
 
2011 AUC for Echocardiography 
ECHOCARDIOGRAPHY APPROPRIATE USE CRITERIA BY INDICATION  
   
INDICATION DESCRIPTION AU SCORE 
 TTE for general evaluation of cardiac structure and function  
 Suspected Cardiac Etiology-General with TTE  
1 Symptoms or conditions potentially related to suspected cardiac etiology 
including but not limited to chest pain, SOB, palpitations, TIA, stroke, or 
peripheral embolic event. A (9) 
2 Prior testing that is concerning for heart disease or structural abnormality 
including but not limited to chest X-ray, baseline scout images for stress 
echocardiogram, ECG, or cardiac biomarkers  A (9) 
 Arrhythmias with TTE  
3 Infrequent APCs or infrequent VPCs without other evidence of heart disease
 I (2) 
4 Frequent VPCs or exercise-induced VPCs A (8) 
5 Sustained or non-sustained atrial fibrillation, SVT or VT A (9) 
6 Asymptomatic isolated sinus bradycardia I (2) 
 Light-headedness/Presyncope/Syncope with TTE  
7 Clinical symptoms or signs consistent with a cardiac diagnosis known to cause 
light-headedness/presyncope/syncope (including but not limited to aortic 
stenosis, HCM or HF) A (9) 
8 Light-headedness/presyncope when there are no other symptoms or signs of 
cardiovascular disease I (3) 
9 Syncope when there are no other symptoms or signs of cardiovascular disease 
 A (7) 
 Evaluation of Ventricular Function with TTE  
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10 Initial evaluation of ventricular function (e.g., screening) with no symptoms or 
signs of cardiovascular disease I (2) 
11 Routine surveillance of ventricular function with known CAD and no change in 
clinical status or cardiac exam I (3) 
12 Evaluation of LV function with prior ventricular function evaluation showing 
normal function (.g., prior Echocardiogram, left ventriculogram, CT, SPECT MPI, 
CMR) in patients in whom there has been no change in clinical status or cardiac 
exam  I (1) 
 Perioperative Evaluation with TTE  
13 Routine perioperative evaluation of ventricular function with no symptoms or 
signs of cardiovascular disease I (2) 
14 Routine perioperative evaluation of cardiac structure and function prior to non-
cardiac solid organ transplantation U (6) 
 Pulmonary Hypertension with TTE  
15 Evaluation of suspected pulmonary hypertension including evaluation of right 
ventricular function and estimated pulmonary artery pressure A (9) 
16 Routine surveillance (<1y) of known pulmonary hypertension without change in 
clinical status or cardiac exam I (3) 
17 Routine surveillance (>= 1y) of known pulmonary hypertension without change 
in clinical status or cardiac exam A (7) 
18 Re-evaluation of known pulmonary hypertension if change in clinical status or 
cardiac exam or to guide therapy A (9) 
 
 TTE for Cardiovascular evaluation in an Acute setting   
 Hypotension or Hemodynamic Instability with TTE  
19 Hypotension or hemodynamic instability of uncertain or suspected cardiac  
etiology A (9) 
20 Assessment of volume status in critically ill patient U (5) 
 Myocardial Ischemia/Infarction with TTE  
21 Acute chest pain with suspected MI and non-diagnostic  ECG when a resting 
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echocardiogram can be performed during pain A (9) 
22 Evaluation of a patient without chest pain but with other features of an ischemic 
equivalent or laboratory markers indicative of ongoing MI  A (8) 
23 Suspected complication of myocardial ischemia or infarction, including but not 
limited to acute mitral regurgitation, ventricular septal defect, free-wall 
rupture/tamponade, shock, right ventricular involvement, HF, or thrombus A (9) 
 Evaluation of Ventricular Function after ACS with TTE  
24 Initial evaluation of ventricular function following ACS A (9) 
25 Re-evaluation of ventricular function following ACS during recovery phase when 
results will guide therapy A (9) 
 Respiratory Failure with TTE  
26 Respiratory failure or hypoxemia of uncertain etiology A (8) 
27 Respiratory failure or hypoxemia when a non-cardiac etiology of respiratory 
failure has been established U (5) 
 Pulmonary Embolism with TTE  
28 Suspected pulmonary embolism in order to establish diagnosis I (2) 
29 Known acute pulmonary embolism to guide therapy (e.g., thrombectomy and 
thrombolytics) A (8) 
30 Routine surveillance of prior pulmonary embolism with normal right ventricular 
function and pulmonary artery systolic pressureI (1) 
31 Re-evaluation of known pulmonary embolism after thrombolysis or 
thrombectomy for assessment of change in right ventricular function and or 
pulmonary artery pressure A (7) 
 Cardiac Trauma with TTE  
32 Severe deceleration injury or chest trauma when valve injury, pericardial 
effusion, or cardiac injury are possible or suspected A (9) 
33 Routine evaluation in the setting of mild chest trauma with no 
electrocardiographic changes or biomarker elevation I (2) 
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 TTE for evaluation of valvular function  
 Murmur or Click with TTE  
34 Initial evaluation when there is a reasonable suspicion of vulvular or structural 
heart disease A (9) 
35 Initial evaluation when there are no other symptoms or signs of vulvular or 
structural heart disease  I (2) 
36 Re-evaluation in a patient without valvular disease on a prior echocardiogram 
and no change in clinical status or cardiac exam I (1) 
37 Re-evaluation of known valvular heart disease with a change in clinical status or 
cardiac exam or to guide therapy   A (9) 
  
Native Valvular Stenosis with TTE  
38 Routine surveillance (<3 y) of mild valvular stenosis without a change in clinical 
status or cardiac exam I (3) 
39 Routine surveillance (>=3 y) of mild valvular stenosis without a change in clinical 
status or cardiac exam A (7) 
40 Routine surveillance (<1 y) of moderate to severe valvular stenosis without a 
change in clinical status or cardiac exam I (3) 
41 Routine surveillance (>=1 y) of moderate or severe valvular stenosis without a 
change in clinical status or cardiac exam A (8) 
 Native Valvular Regurgitation with TTE  
42 Routine surveillance of trace valvular regurgitation I (1) 
43  Routine surveillance (<3 y) of mild valvular regurgitation without a change in 
clinical status or cardiac exam  I (2) 
44 Routine surveillance  (>=3 y)  of mild valvular regurgitation without a change in 
clinical status or cardiac exam U (4) 
45 Routine surveillance (<1 y) of moderate or severe valvular regurgitation without 
a change in clinical status or cardiac exam U (6) 
46 Routine surveillance (>=1 y) of moderate or severe valvular regurgitation without 
change in clinical status or cardiac exam A (8) 
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  Prosthetic Valves With TTE   
47 Initial postoperative evaluation of prosthetic valve for establishment of baseline
 A (9) 
48 Routine surveillance (<3 y after valve implantation) of prosthetic valve if no 
known or suspected valve dysfunction  I (3) 
49 Routine surveillance (>=3 y after valve implantation) of prosthetic valve if no 
known or suspected valve dysfunction A (7) 
50 Evaluation of prosthetic valve with suspected dysfunction or a change in clinical 
status or cardiac exam A (9) 
51 Re-evaluation of known prosthetic valve dysfunction when it would change 
management or guide therapy A (9) 
  Infective Endocarditis (Native or Prosthetic Valves) With TTE   
52 Initial evaluation of suspected infective endocarditis with positive blood cultures 
or a new murmur A (9) 
53 Transient fever without evidence of bacteremia or a new murmur I (2) 
54  Transient bacteremia with a pathogen not typically associated with infective 
endocarditis and/or a documented non-endovascular source of infection I (3) 
55 Re-evaluation of infective endocarditis at high risk for progression or 
complication or with a change in clinical status or cardiac exam  A (9) 
56  Routine surveillance of uncomplicated infective endocarditis when no change in 
management is contemplated I (2) 
 
  TTE for evaluation of intra-cardiac and extra-cardiac structures and 
chambers 
57 Suspected cardiac mass  A (9) 
58 Suspected cardiovascular source of embolus A (9) 
59 Suspected pericardial conditions  A (9) 
60 Routine surveillance of known small pericardial effusion with no change in 
clinical status I (2) 
61 Re-evaluation of known pericardial effusion to guide management or therapy
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  A (8) 
62 Guidance of percutaneous non-coronary cardiac procedures including but not 
limited to pericardiocentesis, septal ablation, or right ventricular biopsy A (9) 
 
  TTE for evaluation of aortic disease   
63  Evaluation of the ascending aorta in the setting of a known or suspected 
connective tissue disease or genetic condition that predisposes to aortic 
aneurysm or dissection (e.g., Marfan syndrome)  A (9) 
64  Re-evaluation of known ascending aortic dilation or history of aortic dissection 
to establish a baseline rate of expansion or when the rate of expansion is 
excessive A (9) 
65 Re-evaluation of known ascending aortic dilation or history of aortic dissection 
with a change in clinical status or cardiac exam or when findings may alter 
management or therapy  A (9) 
66 Routine re-evaluation for surveillance of known ascending aortic dilation or 
history of aortic dissection without a change in clinical status or cardiac exam 
when findings would not change management or therapy I (3) 
 
 TTE for evaluation of hypertension, HF, or cardiomyopathy  
  Hypertension With TTE   
67 Initial evaluation of suspected hypertensive heart disease A (8) 
68 Routine evaluation of systemic hypertension without symptoms or signs of 
hypertensive heart disease I (3) 
69 Re-evaluation of known hypertensive heart disease without a change in clinical 
status or cardiac exam U (4) 
  HF With TTE   
70 Initial evaluation of known or suspected HF (systolic or diastolic) based on 
symptoms, signs, or abnormal test results A (9) 
71 Re-evaluation of known HF (systolic or diastolic) with a change in clinical status 
or cardiac exam without a clear precipitating change in medication or diet  A (8) 
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72 Re-evaluation of known HF (systolic or diastolic) with a change in clinical status 
or cardiac exam with a clear precipitating change in medication or diet U (4) 
73 Re-evaluation of known HF (systolic or diastolic) to guide therapy A (9) 
74 Routine surveillance (<1 y) of HF (systolic or diastolic) when there is no change 
in clinical status or cardiac exam I (2) 
75 Routine surveillance (>=1 y) of HF (systolic or diastolic) when there is no change 
in clinical status or cardiac exam U (6) 
 Device Evaluation (Including Pacemaker, ICD, or CRT) with TTE   
76 Initial evaluation or re-evaluation after revascularization and/or optimal medical 
therapy to determine candidacy for device therapy and/or to determine optimal 
choice of device A (9) 
77 Initial evaluation for CRT device optimization after implantation U (6) 
78  Known implanted pacing device with symptoms possibly due to device 
complication or suboptimal pacing device settings A (8)  
79 Routine surveillance (<1 y) of implanted device without a change in clinical 
status or cardiac exam I (1) 
80 Routine surveillance (>=1 y) of implanted device without a change in clinical 
status or cardiac exam I (3) 
 Ventricular Assist Devices and Cardiac Transplantation With TTE  
81 To determine candidacy for ventricular assist device A (9) 
82 Optimization of ventricular assist device settings A (7) 
83 Re-valuation for signs/symptoms suggestive of ventricular assist device-related 
complications A (9) 
84 Monitoring for rejection in a cardiac transplant recipient A (7) 
85 Cardiac structure and function evaluation in a potential heart donor A (9) 
 Cardiomyopathies With TTE  
86  Initial evaluation of known or suspected cardiomyopathy (e.g., restrictive, 
infiltrative, dilated, hypertrophic, or genetic cardiomyopathy) A (9) 
87 Re-evaluation of known cardiomyopathy with a change in clinical status or 
cardiac exam or to guide therapy A (9) 
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88 Routine surveillance (<1 y) of known cardiomyopathy without a change in clinical 
status or cardiac exam  
I (2) 
89 Routine surveillance (>=1 y) of known cardiomyopathy without a change in 
clinical status or cardiac exam U (5) 
90 Screening evaluation for structure and function in first - degree relatives of a 
patient with an inherited cardiomyopathy A (9) 
91 Baseline and serial re-evaluations in a patient undergoing therapy with 
cardiotoxic agents A (9) 
 
 TTE for adult congenital heart disease  
92 Initial evaluation of known or suspected adult congenital heart disease A (9) 
93 Known adult congenital heart disease with a change in clinical status or cardiac 
exam A (9) 
94 Re-evaluation to guide therapy in known adult congenital heart disease A (9) 
95 Routine surveillance (<2 y) of adult congenital heart disease following complete 
repair 
-without a residual structural or hemodynamic abnormality  
- without a change in clinical status or cardiac exam I (3) 
96  Routine surveillance (>=2 y) of adult congenital heart disease following 
complete repair 
-without residual structural or hemodynamic abnormality  
-without a change in clinical status or cardiac exam U (6)  
97 Routine surveillance (<1 y) of adult congenital heart disease following 
incomplete or palliative repair 
- with residual structural or hemodynamic abnormality  
- without a change in clinical status or cardiac exam U (5) 
98  Routine surveillance (>=1 y) of adult congenital heart disease following 
incomplete or palliative repair 
- with residual structural or hemodynamic abnormality  
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- without a change in clinical status or cardiac exam A (8)  
 TEE  
  TEE as Initial or Supplemental Test—General Uses    
99 Use of TEE when there is a high likelihood of a non-diagnostic TTE due to 
patient characteristics or inadequate visualization of relevant structures A (8) 
100  Routine use of TEE when a diagnostic TTE is reasonably anticipated to resolve 
all diagnostic and management concerns I (1)  
101 Re-evaluation of prior TEE finding for interval change (e.g., resolution of 
thrombus after anticoagulation, resolution of vegetation after antibiotic therapy) 
when a change in therapy is anticipated A (8) 
102 Surveillance of prior TEE finding for interval change (e.g., resolution of thrombus 
after anticoagulation, resolution of vegetation after antibiotic therapy) when no 
change in therapy is anticipated  I (2) 
103 Guidance during percutaneous non-coronary cardiac interventions including but 
not limited to closure device placement, radiofrequency ablation, and 
percutaneous valve procedures A (9) 
104 Suspected acute aortic pathology including but not limited to 
dissection/transection A (9) 
105 Routine assessment of pulmonary veins in an asymptomatic patient status post 
pulmonary vein isolation I (3) 
  TEE as Initial or Supplemental Test—Valvular Disease   
106 Evaluation of valvular structure and function to assess suitability for, and assist 
in planning of, an intervention A (9) 
107  To diagnose infective endocarditis with a low pretest probability (e.g., transient 
fever, known  alternative source of infection, or negative blood cultures/atypical 
pathogen for endocarditis) I (3) 
108 To diagnose infective endocarditis with a moderate or high pretest probability 
(e.g., staph bacteremia, fungemia, prosthetic heart valve, or intra-cardiac 
device) A (9) 
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  TEE as Initial or Supplemental Test—Embolic Event   
109 Evaluation for cardiovascular source of embolus with no identified non-cardiac 
source A (7) 
110  Evaluation for cardiovascular source of embolus with a previously identified 
non-cardiac source U (5) 
111 Evaluation for cardiovascular source of embolus with a known cardiac source in 
which a TEE would not change management I (1) 
  TEE as Initial Test—Atrial Fibrillation/Flutter    
112 Evaluation to facilitate clinical decision making with regard to anticoagulation, 
cardioversion, and/or radiofrequency ablation A (9) 
113 Evaluation when a decision has been made to anticoagulate and not to perform 
cardioversion I (2) 
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Appendix 8: Profile of Inappropriate Referrals  
 
The following discussion summarizes the inappropriately referred patients only. 
 
Patient 1 was an 18-year-old female who was referred for assessment for cancer 
chemotherapy and had a normal heart on echocardiography. But the 
echocardiography indication was not documented clearly on the 
echocardiography request form and had to be inferred by the treating 
cardiologist. 
 
Patient 2 was a 35-year-old male being investigated for possible palpitations. 
Again this was not clearly indicated in the request form. He had a normal study 
on echocardiography. 
 
Patient 3 was a 51-year-old female with retroviral disease and no other clear 
indication for echocardiography was specified. The echocardiography was 
normal in this patient as well. 
 
Patient 4 was a 43-year-old male with retroviral disease with no other 
documented indication for an echocardiogram. The echocardiography was also 
normal. 
 
Patient 5 had no age specified and no indication as well for the echocardiogram 
request form. She was found to have a normal study. 
 
Patient 6 was a 42-year-old female with no indication noted on the request form. 
She was found to have a normal study. 
 
Patient 7 was a 17-year-old female with a possible connective tissue disease 
who had a normal study done 
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Patient 8 was a 30-year-old diabetic male who was found to have a 
cardiomyopathy on echocardiography. 
 
Patient 9 was a 24-year-old female also being worked up for a connective tissue 
disorder, and was found to have a pericardial effusion 
 
Patient 10 was a 26-year-old female with a connective tissue disorder and she 
had a normal study on echocardiography 
 
